Bank of New York Mellon’s Spero Therapeutics SPRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-14,966
| Closed | -$11K | – | 4595 |
|
|
2022
Q2 | $11K | Sell |
14,966
-58,104
| -80% | -$42.7K | ﹤0.01% | 4542 |
|
|
2022
Q1 | $636K | Sell |
73,070
-1,930
| -3% | -$16.8K | ﹤0.01% | 3569 |
|
|
2021
Q4 | $1.2M | Buy |
75,000
+793
| +1% | +$12.7K | ﹤0.01% | 3275 |
|
|
2021
Q3 | $1.37M | Buy |
74,207
+7,612
| +11% | +$140K | ﹤0.01% | 3220 |
|
|
2021
Q2 | $930K | Buy |
66,595
+3,423
| +5% | +$47.8K | ﹤0.01% | 3464 |
|
|
2021
Q1 | $931K | Sell |
63,172
-6,711
| -10% | -$98.9K | ﹤0.01% | 3374 |
|
|
2020
Q4 | $1.36M | Buy |
69,883
+18,357
| +36% | +$356K | ﹤0.01% | 3067 |
|
|
2020
Q3 | $575K | Buy |
51,526
+1,589
| +3% | +$17.7K | ﹤0.01% | 3420 |
|
|
2020
Q2 | $676K | Buy |
49,937
+3,873
| +8% | +$52.4K | ﹤0.01% | 3316 |
|
|
2020
Q1 | $371K | Buy |
46,064
+8,290
| +22% | +$66.8K | ﹤0.01% | 3509 |
|
|
2019
Q4 | $363K | Buy |
37,774
+551
| +1% | +$5.3K | ﹤0.01% | 3726 |
|
|
2019
Q3 | $395K | Buy |
37,223
+2,944
| +9% | +$31.2K | ﹤0.01% | 3672 |
|
|
2019
Q2 | $395K | Buy |
34,279
+708
| +2% | +$8.16K | ﹤0.01% | 3709 |
|
|
2019
Q1 | $430K | Sell |
33,571
-3,145
| -9% | -$40.3K | ﹤0.01% | 3615 |
|
|
2018
Q4 | $226K | Buy |
36,716
+8,888
| +32% | +$54.7K | ﹤0.01% | 3815 |
|
|
2018
Q3 | $293K | Buy |
27,828
+3,139
| +13% | +$33.1K | ﹤0.01% | 3823 |
|
|
2018
Q2 | $363K | Buy |
24,689
+10,490
| +74% | +$154K | ﹤0.01% | 3769 |
|
|
2018
Q1 | $202K | Buy |
+14,199
| New | +$202K | ﹤0.01% | 3920 |
|